Fanconi syndrome primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vahid Eidkhani, M.D.

Prevention of Fanconi syndrome mostly depends on early diagnosis, treatment and management of potential underlying diseases and/or preventing the toxicity of the exposure to exogenous precipitating factors.

Diagnosis, treatment and management of these potential underlying diseases in their early stages may prevent Fanconi syndrome’s progression or even onset^[1][2][3]:

• Cystinosis medical therapy
• Wilson disease medical therapy
• and to a lesser extent Tyrosinemia medical therapy ( late onset Tyrosinemia lead to best results)

Preventing the toxicity of the exposure to exogenous precipitating factors may prevent Fanconi syndrome’s progression or even onset:

• Galactosemia, Galctose consumption restriction
• Hereditary fructose intolerance, Fructose consumption restriction
• Tyrosinemia, tyrosine/phenylalanine consumption restriction
• Any precipitating drug or heavy metal exposure restriction or adjustment, including: Nucleoside Reverse Transcriptase Inhibitors, Valproic acid, Aminoglycosides, tetracyclines, cadmium and lead

Template:WH Template:WS